8045211000001101: Vesicare 5mg tablets (Yamanouchi Pharmaceuticals) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Virtual medicinal product\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Virtual therapeutic moiety\Solifenacin\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Virtual therapeutic moiety\Solifenacin\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Trade family\Vesicare\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)

\Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing solifenacin\Solifenacin\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing solifenacin\Solifenacin\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing solifenacin\Product containing solifenacin in oral dose form (medicinal product form)\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing solifenacin\Solifenacin\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing solifenacin\Solifenacin\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing solifenacin\Product containing solifenacin in oral dose form (medicinal product form)\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Product manufactured as oral dose form\Product containing solifenacin in oral dose form (medicinal product form)\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing solifenacin\Solifenacin\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing solifenacin\Solifenacin\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing solifenacin\Product containing solifenacin in oral dose form (medicinal product form)\Product containing only solifenacin in oral dose form (medicinal product form)\Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet\Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

20680901000001116 Vesicare 5mg tablets (Yamanouchi Pharmaceuticals) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

39230501000001119 Vesicare 5mg tablets (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Is a	Solifenacin 5mg tablets	false	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has active ingredient	Solifenacin succinate	false	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Is a	Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has active ingredient	Solifenacin succinate	false	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Is a	Vesicare	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has specific active ingredient	Solifenacin succinate	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals) 30 tablet 3 x 10 tablets	Is pack of	False	Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Inferred relationship	Existential restriction modifier
Vesicare 5mg tablets (Yamanouchi Pharmaceuticals) 30 tablet 3 x 10 tablets	Has AMP	True	Vesicare 5mg tablets (Yamanouchi Pharmaceuticals)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
20680901000001116	Vesicare 5mg tablets (Yamanouchi Pharmaceuticals) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
39230501000001119	Vesicare 5mg tablets (Astellas Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module